Evaluating adherence to guidelines for managing dyslipidemia
Observatory of Patients With Dyslipidemia Hospitalized in Endocrinology-Diabetology-Nutrition Unit: Observational Study
This study looks at how well doctors follow guidelines for treating high cholesterol in hospitalized patients over 18 to see if they can improve care and outcomes for these individuals.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 977 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT03449784 on ClinicalTrials.gov |
What this trial studies
This observational study assesses how well healthcare providers comply with European and French guidelines for managing dyslipidemia in hospitalized patients. It focuses on patients aged over 18 who have been admitted for at least 24 hours and have had blood samples taken to measure lipid levels. The study aims to identify gaps in adherence to guidelines and improve the management of dyslipidemia, which is a significant risk factor for cardiovascular diseases. By analyzing patient data, the study seeks to enhance treatment strategies and outcomes for individuals with dyslipidemia.
Who should consider this trial
Good fit: Ideal candidates are hospitalized patients over 18 years old with dyslipidemia who have had blood samples taken within 24 hours of admission.
Not a fit: Patients with significantly elevated triglycerides (greater than 4.5 mmol/L or 400 mg/dL) may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management of dyslipidemia, reducing cardiovascular risks for patients.
How similar studies have performed: Other studies have shown success in improving dyslipidemia management through adherence to clinical guidelines, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: \- Patients aged above 18 years old, admitted to the department during the study period and hospitalized for at least 24 hours, blood samples taken within 24 hours of hospitalization admission (LDL-C, triglycerides) Exclusion criteria: \- Patients with elevated triglycerides (\>4.5 mmol/L or \>400 mg/dL)
Where this trial is running
Montpellier
- Uhmontpellier — Montpellier, France (Recruiting)
Study contacts
- Principal investigator: Cyril BREUKER — University Hospital, Montpellier
- Study coordinator: Cyril BREUKER, PharmD,Phd
- Email: c-breuker@chu-montpellier.fr
- Phone: 467337121
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.